|
End-of-day quote
Taipei Exchange
04/09/2026
|
5-day change | 1st Jan Change | ||
| 145.50 TWD | +23.31% |
|
+54.95% | +266.50% |
| 08-14 | Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-28 | Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LIN BIOSCIENCE, INC. | Other Pharmaceuticals | +23.31% | +54.95% | +266.50% | +781.82% | +857.24% | 3.81B |  | | |
- Stock Market
- Stocks
- 6696 Stock
- Charts Lin BioScience, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
